{"id":"2aabc866-3715-5bba-aa33-be101dc1afc8","stable_key":"44eaeae5-557a-552b-8998-884f30462e2a:sulforaphane-gsh-gates-induction","predicate":"reduced","statement":"BSO pretreatment significantly reduced sulforaphane-induced TXNRD1 mRNA.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"6c854bb6-ffeb-570f-a674-efea6e9243fa","mechanism_event_label":"The signaling response depended on the surrounding glutathione system.","subject":{"id":"c4cdd58b-6599-5aea-9245-74e05eea1644","slug":"gcl-pharmacological-inhibition","display_name":"Pharmacological inhibition of glutathione synthesis by BSO","entity_type_key":"protein_state"},"object":{"id":"b7a298df-a1a3-53a9-aca4-6ee8bc6bac63","slug":"txnrd1-mrna-abundance","display_name":"Human TXNRD1 mRNA abundance","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"6c854bb6-ffeb-570f-a674-efea6e9243fa","stable_key":"44eaeae5-557a-552b-8998-884f30462e2a:sulforaphane-gsh-gates-induction-event","event_type":"biochemical_relationship","label":"The signaling response depended on the surrounding glutathione system.","description":"BSO pretreatment significantly reduced sulforaphane-induced TXNRD1 mRNA.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"b44c9e27-4bbb-52d3-a022-14cddded5073","slug":"glutathione","display_name":"GSH","entity_type_key":"small_molecule"},"role":"affected_pool","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"67e70215-70c4-546a-84b4-0819fac0b326","slug":"sulforaphane","display_name":"Sulforaphane / SFN, stereochemistry specified per study","entity_type_key":"small_molecule"},"role":"inducer","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"64fac263-c4d5-51c8-beba-d061868b0ce2","slug":"txnrd1","display_name":"TXNRD1","entity_type_key":"protein"},"role":"response_enzyme","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"c4cdd58b-6599-5aea-9245-74e05eea1644","slug":"gcl-pharmacological-inhibition","display_name":"Pharmacological inhibition of glutathione synthesis by BSO","entity_type_key":"protein_state"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"b7a298df-a1a3-53a9-aca4-6ee8bc6bac63","slug":"txnrd1-mrna-abundance","display_name":"Human TXNRD1 mRNA abundance","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/sulforaphane-research/12663510.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9\", \"start_char\": 0, \"end_char\": 1535, \"text_sha256\": \"95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Transcription/translation and inhibitor experiments","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Sulforaphane, sodium selenite, combined treatment and pathway inhibitors","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Sulforaphane research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"sulforaphane","display_name":"Sulforaphane / SFN, stereochemistry specified per study","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Human HepG2 hepatoma cells","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The signaling response depended on the surrounding glutathione system.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Thioredoxin reductase regulation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"fadd57ff-8a21-5b88-8c0a-5b7c41360624","evidence_kind":"source_excerpt","locator":"Lines 762-773","start_line":762,"end_line":773,"excerpt":"### sulforaphane-gsh-gates-induction\nBSO pretreatment significantly reduced sulforaphane-induced TXNRD1 mRNA.\nCondition category: machinery_impairment\nnutrient_topic: Sulforaphane research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The signaling response depended on the surrounding glutathione system.\norganism: Human HepG2 hepatoma cells\ntissue_or_cell_type: Thioredoxin reductase regulation\nexperimental_model: Transcription/translation and inhibitor experiments\nlimitations: Cell-culture synergy at specified exposures is not a clinical supplement recommendation; TXNRD1 and TXNRD2 were not interchangeable.\nexposure: Sulforaphane, sodium selenite, combined treatment and pathway inhibitors\nevidence_span: {\"source_cache\": \"artifacts/sulforaphane-research/12663510.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9\", \"start_char\": 0, \"end_char\": 1535, \"text_sha256\": \"95f1de031ede41aa12f975dff28193dcb426465d4bda94bb84d4e60ef6c292b9\"}\n[sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497","model_system":"Transcription/translation and inhibitor experiments","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [sulforaphane-p12663510] Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. (2003). https://pubmed.ncbi.nlm.nih.gov/12663510/ DOI: 10.1093/carcin/24.3.497","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"a4bafbf7-f117-53c9-a6d7-8fb25e4aca72","stable_key":"import-44eaeae5-557a-552b-8998-884f30462e2a","title":"Sulforaphane: formation, electrophile sensing and nutrient connections (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"f355c492a6c35673d8260b1328667fe206e5315b9fcaa5aeff53d80373c7ef97","revision_id":"f2c47d71-34cd-5160-8e92-fe196b576707","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}